Eli Lilly won't lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an AI-powered scheduling assistant.

CVS stock has an attractive yield and earnings expansion. That makes it worth a look for investors seeking growth and income.